by Market Overview:
Candidiasis is a fungal infection caused by any type of Candida (a type of yeast). It can cause infections of the mouth, throat, esophagus, lungs, bloodstream, and other parts of the body. Candida infections commonly appear in the mouth or vagina and may cause redness, itching, discharge, burning sensation or other signs and symptoms depending on the infected area of the body.
Market Key Trends:
Growing prevalence of HIV/AIDS diseases is a major driver for the Candidiasis market. According to UNAIDS, nearly 37.9 million people were living with HIV/AIDS globally and 770 thousand deaths as a result of AIDS related illnesses in 2018. This weakens the immunity and allows Candida infection to occur easily. Other major trend is the rising adoption of telehealth due to the COVID-19 pandemic. Telehealth enables effective remote monitoring of patients and helps physician determine the severity and manage candidiasis cases without physical examination.
Segment Analysis
The global Candidiasis market is segmented by drug class into azoles, echinocandins, and polyenes. The azoles segment currently dominates the market due to the wide availability and preference of oral azole medications such as fluconazole for treatment of most Candida infections. The polyenes segment is expected to witness moderate growth owing to high toxicity and other side effects associated with this drug class.
Key Takeaways:
The Global Candidiasis Market Demand is expected to witness high growth, exhibiting a CAGR of 3.2% over the forecast period, due to the increasing prevalence of HIV/AIDS infections and growing number of surgical procedures across the world.
Regional analysis: North America dominated the global Candidiasis market in 2023 due to the presence of major market players and availability of reimbursement in the region. Asia Pacific is anticipated to grow at the fastest rate during the forecast period owing to rising healthcare investments and increase in number of surgical procedures in developing countries like India and China.
Key players: Key players operating in the Candidiasis market are Bayer, Teva Pharmaceuticals, Stellar Pharma, Pfizer, Wockhardt, Ranbaxy, Bristol Laboratories, Glenmark Pharmaceuticals, Taro Pharmaceuticals and Perrigo among many other local players. The major players are focusing on new product developments as well as adopting expansion strategies to strengthen their global presence.
Note:
- Source: Coherent Market Insights, Public sources, Desk research
- We have leveraged AI tools to mine information and compile it
